|
|
||||||||



*
Division of Rheumatology and Immunology,
Department of Pediatrics, and Center for Gastroenterology Research on Absorptive and Secretory Processes, Tufts University School of Medicine and New England Medical Center, and
Immunology Program, Department of Pathology, Tufts University School of Medicine, Boston, MA 02111
Previous studies have demonstrated that an MHC class II molecule
with an antigenic peptide genetically fused to its
-chain is capable
of presenting this peptide to CD4+ T cells. We hypothesized
that covalent peptide/class II complex may direct the accessory
molecules to exert their function specifically onto T cells in a
TCR-guided fashion. To test this hypothesis, we generated several
recombinant adenoviruses expressing covalent myelin basic protein
peptide/I-Au complex
(MBP111/I-Au) and the costimulatory molecule
B7-1. Functional studies demonstrated that adenovirus-infected cells
are capable of activating an MBP111-specific T cell
hybridoma. Coexpression of the B7-1 molecule and
MBP111/I-Au by the same adenovirus leads to
synergy in T cell activation elicited by virus-infected cells.
Furthermore, studies in syngeneic mice infected with the various
adenoviruses revealed that MBP111-specific T cells are
specifically activated by the coexpression of B7-1 and
MBP111/I-Au in vivo. In conclusion, the
coexpression of the covalent peptide/class II complex and accessory
molecules by the same adenovirus provides a unique strategy to modulate
the epitope-specific T cell response in a TCR-guided fashion. This
approach may be applicable to investigate the roles of other accessory
molecules in the engagement of the TCR class II molecule by
substituting B7-1 with other accessory molecules in the recombinant
adenovirus.
This article has been cited by other articles:
![]() |
G. T. Gurda, L. Guo, S.-H. Lee, J. D. Molkentin, and J. A. Williams Cholecystokinin Activates Pancreatic Calcineurin-NFAT Signaling In Vitro and In Vivo Mol. Biol. Cell, January 1, 2008; 19(1): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Carlson, M. Lin, C.-Y. Liu, W. W-Y. Kao, V. L. Perez, and E. Pearlman Keratocan and Lumican Regulate Neutrophil Infiltration and Corneal Clarity in Lipopolysaccharide-induced Keratitis by Direct Interaction with CXCL1 J. Biol. Chem., December 7, 2007; 282(49): 35502 - 35509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ouyang, Y.-C. Shen, L.-K. Yeh, W. Li, B. M. Coyle, C.-Y. Liu, and M. E. Fini Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2397 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawakita, E. M. Espana, H. He, R. Smiddy, J.-M. Parel, C.-Y. Liu, and S. C. G. Tseng Preservation and Expansion of the Primate Keratocyte Phenotype by Downregulating TGF-{beta} Signaling in a Low-Calcium, Serum-Free Medium Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1918 - 1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Liu, F. Shang, E. Whitcomb, W. Guo, W. Li, and A. Taylor Ubiquitin-conjugating enzyme 3 delays human lens epithelial cells in metaphase. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1302 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Kurschus, T. Oelert, B. Liliensiek, P. Buchmann, D. C. Wraith, G. J. Hammerling, and B. Arnold Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP1-10 covalently bound to the MHC class II molecule I-Au Int. Immunol., January 1, 2006; 18(1): 151 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawakita, E. M. Espana, H. He, A. Hornia, L.-K. Yeh, J. Ouyang, C.-Y. Liu, and S. C. G. Tseng Keratocan Expression of Murine Keratocytes Is Maintained on Amniotic Membrane by Down-regulating Transforming Growth Factor-{beta} Signaling J. Biol. Chem., July 22, 2005; 280(29): 27085 - 27092. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sutkowski, G. Chen, G. Calderon, and B. T. Huber Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen J. Virol., July 15, 2004; 78(14): 7852 - 7860. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagayama, M. Kita-Furuyama, T. Ando, K. Nakao, H. Mizuguchi, T. Hayakawa, K. Eguchi, and M. Niwa A Novel Murine Model of Graves' Hyperthyroidism with Intramuscular Injection of Adenovirus Expressing the Thyrotropin Receptor J. Immunol., March 15, 2002; 168(6): 2789 - 2794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |